Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

T CELL RECEPTOR LIGANDS AND METHODS OF USING SAME

  • Read more about T CELL RECEPTOR LIGANDS AND METHODS OF USING SAME
US Application 10/193,474
Filed on 2002-07-10

Major Neutralization Site Of Hepatitis E Virus And Use Of This Neutralization Site In Methods Of Vaccination And In Methods Of Screening for Neutralizing Antibodies to Hepatitis E Virus

  • Read more about Major Neutralization Site Of Hepatitis E Virus And Use Of This Neutralization Site In Methods Of Vaccination And In Methods Of Screening for Neutralizing Antibodies to Hepatitis E Virus
US Patent 6,930,176
Filed on 2003-01-27

ACYLTHIOL AND COMPONENT THIOL COMPOSITIONS AS ANTI-HIV AND ANTI- RETROVIRAL AGENTS

  • Read more about ACYLTHIOL AND COMPONENT THIOL COMPOSITIONS AS ANTI-HIV AND ANTI- RETROVIRAL AGENTS
Patent Cooperation Treaty
PCT/US2002/023924
Filed on 2002-07-25

HEPATITIS A VIRUS VACCINES

  • Read more about HEPATITIS A VIRUS VACCINES
US Patent 6,680,060
Filed on 2002-04-29

BINDING DOMAINS FROM PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM ERYTHROCYTE BINDING PROTEINS

  • Read more about BINDING DOMAINS FROM PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM ERYTHROCYTE BINDING PROTEINS
US Patent 6,962,987
Filed on 2002-05-21

METHODS OF TREATING INFLAMMATORY BOWEL DISEASE USING CHOLERA TOXIN B SUBUNIT

  • Read more about METHODS OF TREATING INFLAMMATORY BOWEL DISEASE USING CHOLERA TOXIN B SUBUNIT
US Patent 7,041,296
Filed on 2002-09-17

Production of Attenuated Human-Bovine Chimeric Respiratory Syncytial Virus Vaccines

  • Read more about Production of Attenuated Human-Bovine Chimeric Respiratory Syncytial Virus Vaccines
US Application 10/031,095
Filed on 2002-01-09

ATTENUATED HUMAN ROTAVIRUS VACCINE

  • Read more about ATTENUATED HUMAN ROTAVIRUS VACCINE
Patent Cooperation Treaty
PCT/US95/008665
Filed on 1995-07-11

Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric

  • Read more about Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric
Patent Cooperation Treaty
PCT/US2002/016308
Filed on 2002-05-22

Recombinant ORF2 Proteins of the Swine Hepatitis E Virus and Their Use as A Vaccine and as a Diagnostic Reagent for Medical and Vetinirary Applications

  • Read more about Recombinant ORF2 Proteins of the Swine Hepatitis E Virus and Their Use as A Vaccine and as a Diagnostic Reagent for Medical and Vetinirary Applications
Patent Cooperation Treaty
PCT/US02/14100
Filed on 2002-05-02

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 537
  • Page 538
  • Page 539
  • Page 540
  • Page 541
  • Page 542
  • Page 543
  • Page 544
  • Page 545
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health